To investigate the potential clinical association between RBMS1 and PD-L1, we measured the protein levels of RBMS1 and PD-L1 on human breast cancer tissue microarrays containing 50 breast cancer patient samples by immunohistochemistry (IHC) assay (Fig. 1G). The gene discussed is RBMS1; the disease is breast carcinoma.